Clinical Features, Molecular Heterogeneity, and Prognostic Implications in YARS2-Related Mitochondrial Myopathy
暂无分享,去创建一个
Robert W. Taylor | D. Turnbull | H. Prokisch | D. Murdoch | T. Haack | M. Farrugia | L. Bindoff | A. Schaefer | G. Gorman | G. Falkous | J. Rawles | J. Dean | C. Longman | R. Petty | M. de Visser | C. Donnini | C. Dallabona | C. Alston | Langping He | R. Mcfarland | E. Sommerville | Y. Ng | Micol Gilberti | Charlotte V. Knowles | S. L. Chin | Charlotte V. Y. Knowles | Langping He | Robert W. Taylor | D. Turnbull
[1] E. Pegoraro,et al. Clinical and molecular study in a long-surviving patient with MLASA syndrome due to novel PUS1 mutations , 2016, neurogenetics.
[2] M. Fleming,et al. LARS2 Variants Associated with Hydrops, Lactic Acidosis, Sideroblastic Anemia, and Multisystem Failure. , 2015, JIMD reports.
[3] P. Chinnery,et al. Diagnosis of muscle diseases presenting with early respiratory failure , 2015, Journal of Neurology.
[4] Robert W. Taylor,et al. Prevalence of nuclear and mitochondrial DNA mutations related to adult mitochondrial disease , 2015, Annals of neurology.
[5] M. Minczuk,et al. Two Siblings with Homozygous Pathogenic Splice‐Site Variant in Mitochondrial Asparaginyl–tRNA Synthetase (NARS2) , 2015, Human mutation.
[6] C. Elger,et al. A homozygous splice-site mutation in CARS2 is associated with progressive myoclonic epilepsy , 2014, Neurology.
[7] J. Hunter,et al. Mitochondrial myopathy, lactic acidosis, and sideroblastic anemia (MLASA) plus associated with a novel de novo mutation (m.8969G>A) in the mitochondrial encoded ATP6 gene. , 2014, Molecular genetics and metabolism.
[8] K. McKernan,et al. Mutation in The Nuclear‐Encoded Mitochondrial Isoleucyl–tRNA Synthetase IARS2 in Patients with Cataracts, Growth Hormone Deficiency with Short Stature, Partial Sensorineural Deafness, and Peripheral Neuropathy or with Leigh Syndrome , 2014, Human mutation.
[9] E. Holme,et al. Whole exome sequencing reveals mutations in NARS2 and PARS2, encoding the mitochondrial asparaginyl-tRNA synthetase and prolyl-tRNA synthetase, in patients with Alpers syndrome , 2014, Molecular genetics & genomic medicine.
[10] A. Munnich,et al. Unusual clinical expression and long survival of a pseudouridylate synthase (PUS1) mutation into adulthood , 2014, European Journal of Human Genetics.
[11] Beril Talim,et al. Use of whole-exome sequencing to determine the genetic basis of multiple mitochondrial respiratory chain complex deficiencies. , 2014, JAMA.
[12] Robert W. Taylor,et al. Distal weakness with respiratory insufficiency caused by the m.8344A > G “MERRF” mutation , 2014, Neuromuscular Disorders.
[13] M. Minczuk,et al. VARS2 and TARS2 Mutations in Patients with Mitochondrial Encephalomyopathies , 2014, Human mutation.
[14] S. Jongpiputvanich,et al. Fulminant respiratory muscle paralysis, an expanding clinical spectrum of mitochondrial A3243G tRNALeu mutation. , 2014, Journal of the Medical Association of Thailand = Chotmaihet thangphaet.
[15] K. Boycott,et al. Compound heterozygous mutations in glycyl-tRNA synthetase are a proposed cause of systemic mitochondrial disease , 2014, BMC Medical Genetics.
[16] N. Matsumoto,et al. A novel homozygous YARS2 mutation causes severe myopathy, lactic acidosis, and sideroblastic anemia 2 , 2014, Journal of Human Genetics.
[17] J. Christodoulou,et al. Phenotypic variability and identification of novel YARS2 mutations in YARS2 mitochondrial myopathy, lactic acidosis and sideroblastic anaemia , 2013, Orphanet Journal of Rare Diseases.
[18] Robert W. Taylor,et al. Late-onset respiratory failure due to TK2 mutations causing multiple mtDNA deletions , 2013, Neurology.
[19] Ting Wang,et al. Track data hubs enable visualization of user-defined genome-wide annotations on the UCSC Genome Browser , 2013, Bioinform..
[20] S. Rahman,et al. A distinct mitochondrial myopathy, lactic acidosis and sideroblastic anemia (MLASA) phenotype associates with YARS2 mutations , 2013, American journal of medical genetics. Part A.
[21] Jørgen K. Kanters,et al. Mitochondrial Haplogroups Modify the Risk of Developing Hypertrophic Cardiomyopathy in a Danish Population , 2013, PloS one.
[22] T. Walsh,et al. Mutations in LARS2, encoding mitochondrial leucyl-tRNA synthetase, lead to premature ovarian failure and hearing loss in Perrault syndrome. , 2013, American journal of human genetics.
[23] T. Wieland,et al. Exome sequencing reveals de novo WDR45 mutations causing a phenotypically distinct, X-linked dominant form of NBIA. , 2012, American journal of human genetics.
[24] A. Paetau,et al. Mitochondrial phenylalanyl-tRNA synthetase mutations underlie fatal infantile Alpers encephalopathy. , 2012, Human molecular genetics.
[25] Robert W. Taylor,et al. Cardiac involvement in mitochondrial DNA disease: clinical spectrum, diagnosis, and management , 2012, European heart journal.
[26] E. Shoubridge,et al. A novel mutation in YARS2 causes myopathy with lactic acidosis and sideroblastic anemia , 2012, Human mutation.
[27] B. Faircloth,et al. Primer3—new capabilities and interfaces , 2012, Nucleic acids research.
[28] E. Bertini,et al. Leukoencephalopathy with thalamus and brainstem involvement and high lactate 'LTBL' caused by EARS2 mutations. , 2012, Brain : a journal of neurology.
[29] Jean-Pierre Bouchard,et al. Mutations in the Mitochondrial Methionyl-tRNA Synthetase Cause a Neurodegenerative Phenotype in Flies and a Recessive Ataxia (ARSAL) in Humans , 2012, PLoS biology.
[30] Matej Oresic,et al. Exome sequencing identifies mitochondrial alanyl-tRNA synthetase mutations in infantile mitochondrial cardiomyopathy. , 2011, American journal of human genetics.
[31] T. Walsh,et al. Mutations in mitochondrial histidyl tRNA synthetase HARS2 cause ovarian dysgenesis and sensorineural hearing loss of Perrault syndrome , 2011, Proceedings of the National Academy of Sciences.
[32] R. Belostotsky,et al. Mutations in the mitochondrial seryl-tRNA synthetase cause hyperuricemia, pulmonary hypertension, renal failure in infancy and alkalosis, HUPRA syndrome. , 2011, American journal of human genetics.
[33] Günther Specht,et al. HaploGrep: a fast and reliable algorithm for automatic classification of mitochondrial DNA haplogroups , 2011, Human mutation.
[34] F. Foury,et al. In vivo analysis of mtDNA replication defects in yeast. , 2010, Methods.
[35] R. Giegé,et al. Mutation of the mitochondrial tyrosyl-tRNA synthetase gene, YARS2, causes myopathy, lactic acidosis, and sideroblastic anemia--MLASA syndrome. , 2010, American Journal of Human Genetics.
[36] V. Tiranti,et al. Nonsense mutation in pseudouridylate synthase 1 (PUS1) in two brothers affected by myopathy, lactic acidosis and sideroblastic anaemia (MLASA) , 2009, BMJ Case Reports.
[37] J. Gomori,et al. Deleterious mutation in the mitochondrial arginyl-transfer RNA synthetase gene is associated with pontocerebellar hypoplasia. , 2007, American journal of human genetics.
[38] R. Schiffmann,et al. Mitochondrial aspartyl-tRNA synthetase deficiency causes leukoencephalopathy with brain stem and spinal cord involvement and lactate elevation , 2007, Nature Genetics.
[39] V. Álvarez,et al. Mitochondrial DNA haplogroups in Spanish patients with hypertrophic cardiomyopathy. , 2006, International journal of cardiology.
[40] D. Lev,et al. Mitochondrial Myopathy, Sideroblastic Anemia, and Lactic Acidosis: An Autosomal Recessive Syndrome in Persian Jews Caused by a Mutation in the PUS1 Gene , 2005, Journal of child neurology.
[41] Y. Bykhovskaya,et al. Missense mutation in pseudouridine synthase 1 (PUS1) causes mitochondrial myopathy and sideroblastic anemia (MLASA). , 2004, American journal of human genetics.
[42] Robert W. Taylor,et al. The diagnosis of mitochondrial muscle disease , 2004, Neuromuscular Disorders.
[43] K. Casas,et al. Mitochondrial myopathy and sideroblastic anemia , 2004, American journal of medical genetics. Part A.
[44] D. Thorburn,et al. Minimum birth prevalence of mitochondrial respiratory chain disorders in children. , 2003, Brain : a journal of neurology.
[45] Wolzt,et al. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. , 2003, The Journal of the American College of Dentists.
[46] B. Garty,et al. Myopathy, lactic acidosis, and sideroblastic anemia: a new syndrome. , 1995, American journal of medical genetics.
[47] P. Philippsen,et al. New heterologous modules for classical or PCR‐based gene disruptions in Saccharomyces cerevisiae , 1994, Yeast.
[48] M. Labouesse,et al. A family of low and high copy replicative, integrative and single‐stranded S. cerevisiae/E. coli shuttle vectors , 1991, Yeast.
[49] E. Holme,et al. Progressive Increase of the Mutated Mitochondrial DNA Fraction in Kearns-Sayre Syndrome , 1990, Pediatric Research.
[50] S. Ho,et al. Site-directed mutagenesis by overlap extension using the polymerase chain reaction. , 1989, Gene.
[51] P. Schimmel,et al. An E. coli aminoacyl-tRNA synthetase can substitute for yeast mitochondrial enzyme function in vivo , 1987, Cell.
[52] R. Hoffman,et al. A new syndrome of refractory sideroblastic anemia with vacuolization of marrow precursors and exocrine pancreatic dysfunction. , 1979, The Journal of pediatrics.
[53] R. Weller,et al. Familial association of metabolic myopathy, lactic acidosis and sideroblastic anemia. , 1974, The American journal of medicine.
[54] M. Zeviani,et al. A Novel Homozygous YARS2 Mutation in Two Italian Siblings and a Review of Literature. , 2015, JIMD reports.
[55] Robert H Schiestl,et al. Quick and easy yeast transformation using the LiAc/SS carrier DNA/PEG method , 2007, Nature Protocols.
[56] Robert W. Taylor,et al. Biochemical assays of respiratory chain complex activity. , 2007, Methods in cell biology.
[57] E. Brett,et al. Pearson syndrome and mitochondrial encephalomyopathy in a patient with a deletion of mtDNA. , 1991, American journal of human genetics.